| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/29/1997 | WO1997019349A1 Gas analysis |
| 05/29/1997 | WO1997019348A2 Novel emulsion for robust sensing of gases |
| 05/29/1997 | WO1997019345A1 Microsensor and use of such microsensor |
| 05/29/1997 | WO1997019340A1 Apparatus and method for rapid spectrophotometric pre-test screen of specimen for a blood analyzer |
| 05/29/1997 | WO1997019335A1 Dna identification method and apparatus |
| 05/29/1997 | WO1997019325A1 Composite structure resin cure monitoring using an optical fiber grating sensor |
| 05/29/1997 | WO1997019217A2 Control methods and apparatus |
| 05/29/1997 | WO1997019189A1 Flow cytometric pharmacosensitivity assay and method of cancer treatment |
| 05/29/1997 | WO1997019188A1 Detection of biological molecules using chemical amplification and optical sensors |
| 05/29/1997 | WO1997019178A2 Autoantigenic metal proteases and methods of diagnosing autoimmune diseases |
| 05/29/1997 | WO1997019174A1 Virus protein antigens of the jc virus |
| 05/29/1997 | WO1997019171A1 Epithelial membrane protein-1 |
| 05/29/1997 | WO1997019170A1 Receptor and nucleic acid molecule encoding said receptor |
| 05/29/1997 | WO1997019113A2 Monoclonal antiidiotypic antibodies (ab2) and uses thereof |
| 05/29/1997 | WO1997019111A2 Monoclonal antibodies anti-cd6 and their uses |
| 05/29/1997 | WO1997019110A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 05/29/1997 | WO1997019105A1 Multivalent polymers, processes for their preparation, and their use for preparing biologically active compounds. |
| 05/29/1997 | WO1997019100A1 N-1-carboxyalkyl derivatives of lsd |
| 05/29/1997 | WO1997018841A1 Non-invasive localization of a light-emitting conjugate in a mammal |
| 05/29/1997 | WO1997018838A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | WO1997018822A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
| 05/29/1997 | WO1997018790A2 Therapeutic and diagnostic agents for the treatment of microbial infections |
| 05/29/1997 | WO1997015000A3 Method for the determination of gas volume streams in processes of the liquid phase |
| 05/29/1997 | WO1997014029A3 Method for spectrometrically measuring isotopic gas and apparatus thereof |
| 05/29/1997 | WO1997005906A3 Diagnostic and diagnosis method for central nervous abnormality and phenylketonuria |
| 05/29/1997 | WO1996036713A3 Eck receptor ligands |
| 05/29/1997 | CA2238404A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
| 05/29/1997 | CA2238262A1 Therapeutic and diagnostic agents for the treatment of microbial infections |
| 05/29/1997 | CA2238104A1 Dna identification method and apparatus |
| 05/29/1997 | CA2238010A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 05/29/1997 | CA2237808A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | CA2236162A1 Epithelial membrane protein-1 |
| 05/29/1997 | CA2236155A1 Assay for blood clotting factors viii and ix |
| 05/29/1997 | CA2210705A1 Monoclonal antiidiotypic antibodies (ab2) and their uses |
| 05/28/1997 | EP0783685A4 Device and method for measuring charge carrying activity in generally non-conductive materials |
| 05/28/1997 | EP0775913A1 Electrochemical gas sensor |
| 05/28/1997 | EP0775912A1 Apparatus and method for the determination of absolute gas concentrations by using semiconducting gas sensors |
| 05/28/1997 | EP0775743A2 Sustainable chick cell line infected with Marek's disease virus |
| 05/28/1997 | EP0775442A1 Pollen mixture and it's use |
| 05/28/1997 | EP0775315A1 Method for separating and/or screening and/or quantifying one or more infectious compounds and support for implementing said method |
| 05/28/1997 | EP0775314A1 Chemical sensors, in particular silicon-based biosensors |
| 05/28/1997 | EP0775313A1 Methods of capturing species from liquids and assay procedures |
| 05/28/1997 | EP0775312A1 Urinary test strip for determining calcium loss |
| 05/28/1997 | EP0775311A1 Analog heater control for medical instrument |
| 05/28/1997 | EP0775310A1 Systems and methods for identifying and controlling interfaces between blood components |
| 05/28/1997 | EP0775309A1 Method for measuring total body tissue iron stores |
| 05/28/1997 | EP0775308A1 Method and arrangement for determining the ability of wheatflour to bind water |
| 05/28/1997 | EP0775306A1 Apparatus and method for performing microfluidic manipulations for chemical analysis and synthesis |
| 05/28/1997 | EP0775298A1 Automated system and method for simultaneously performing a plurality of signal-base assays |
| 05/28/1997 | EP0775206A1 Dual hybrid system |
| 05/28/1997 | EP0775205A1 Novel cell surface receptor, antibody compositions, and methods of using same |
| 05/28/1997 | EP0775151A2 Sialic acid/fucose based medicaments |
| 05/28/1997 | EP0775128A1 Preparation of immunogens and other conjugates of drugs |
| 05/28/1997 | EP0775116A1 Carbamazepine hydrazides useful in immunoassays |
| 05/28/1997 | EP0775014A1 Membrane filter unit |
| 05/28/1997 | EP0775007A1 Enhanced yield blood processing systems with angled interface control surface |
| 05/28/1997 | EP0774971A1 Synthetic peptide inhibitors of hiv transmission |
| 05/28/1997 | EP0717850B1 Assay kit |
| 05/28/1997 | EP0702789A4 Biosensing meter which detects proper electrode engagement and distinguishes sample and check strips |
| 05/28/1997 | EP0702788A4 Biosensing meter with fail/safe procedures to prevent erroneous indications |
| 05/28/1997 | EP0688430B1 Immobilisation and separation of cells and other particles |
| 05/28/1997 | EP0686264B1 Method for determining the affinity of fibrinogen and derivatives thereof for filamentary forms of yeast, and use thereof for determining pathogenic yeast, particularly in blood culture |
| 05/28/1997 | EP0674734B1 Ski slope maintenance device |
| 05/28/1997 | EP0670892A4 PURIFICATION, COMPOSITION AND SPECIFICITY OF HEPARINASE I, II, AND III FROM -i(FLAVOBACTERIUM HEPARINUM). |
| 05/28/1997 | EP0664885B1 Immobilisation material and apparatus for affinity chromatography with mobile organic solvent phase or reverse micellar phase, immuno assays with this immobilisation material |
| 05/28/1997 | EP0663071A4 Method for prediction of premature labor. |
| 05/28/1997 | EP0660931A4 Fluorescent lipid polymer-macromolecular ligand compositions as detection element in ligand assays. |
| 05/28/1997 | EP0653964B1 Method and device for the inspection of containers on a conveyor |
| 05/28/1997 | EP0653064A4 Clinical test for detection of alzheimer's disease. |
| 05/28/1997 | EP0650473B1 Radioimaging and radiochemotherapy phenolic thioether amines and acyl derivatives thereof for use in diagnosing and treating pigmentation disorders |
| 05/28/1997 | EP0609265B1 Unit-of-use reagent composition for specific binding assays |
| 05/28/1997 | EP0609255B1 Method and composition for determining the immunological activity of bioactive substances |
| 05/28/1997 | EP0571420B1 Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
| 05/28/1997 | EP0512112B1 Anti cd-4 antibodies blocking hiv-induced syncytia |
| 05/28/1997 | EP0472522B1 Method for screening cells or formed bodies with populations expressing selected characteristics |
| 05/28/1997 | EP0466914B1 Immunochromatographic assay and method of using same |
| 05/28/1997 | EP0455705B1 Receptor membranes and ionophore gating |
| 05/28/1997 | EP0440749B1 Manual in situ hybridization assay |
| 05/28/1997 | EP0432221B1 One-step in situ hybridization assay |
| 05/28/1997 | EP0418335B1 Process for the evaluation of the anti-oxidant activity of a chemical or physical agent by means of free radicals |
| 05/28/1997 | EP0403554B1 Placental isoferritins for the prognosis and diagnosis of immunosuppression |
| 05/28/1997 | EP0308493B1 Thickness/density measuring apparatus |
| 05/28/1997 | DE19613829C1 Calibration of semiconductor sensor-gas metering system for measuring harmful gas concentrations |
| 05/28/1997 | DE19601488C1 Measuring device manufacturing method for measuring or testing physiological parameter at biocomponent |
| 05/28/1997 | DE19543993A1 Locating dangerous materials, e.g explosives in ground |
| 05/28/1997 | DE19543674A1 Vorrichtung und Verfahren zur Bestimmung der Steifigkeit von Blattgut, wie z. B. Banknoten Apparatus and method for determining the stiffness of sheet material such. As banknotes |
| 05/28/1997 | DE19543569A1 Verwendung des Lectins Sambucus nigra zur Quantifizierung der endständigen Sialinsäurereste des Human-Transferrin-Moleküls mittels einer vollimmunoenzymatischen Methode (EIA) Use of Sambucus nigra lectin to quantitate the terminal sialic acid residues of human transferrin molecule by means of a vollimmunoenzymatischen method (EIA) |
| 05/28/1997 | DE19543553A1 VP-Antigene des JC-Virus VP-antigens of the JC virus |
| 05/28/1997 | DE19543433A1 Appts. for determining partial pressure of ammonia at high temperature in galvanic measuring cell |
| 05/28/1997 | CN2255045Y Assistant device for analysis |
| 05/28/1997 | CN1150841A Method of selection of population or subpopulation of sample |
| 05/28/1997 | CN1150840A A method for detecting presence of mycobacterium species and kit and antibodies for use therein |
| 05/28/1997 | CN1150839A Device for evaluating cleanliness of metal and method therefor |
| 05/28/1997 | CN1150838A Method of determining cause of defects on steel material surface |
| 05/28/1997 | CN1150820A Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms |
| 05/28/1997 | CN1150805A Isolated peptides derived from MAGE tumor rejection antigen precursops which complex with HLA-A2 molecules |
| 05/28/1997 | CN1150804A Fibroblast growth factor-10 |
| 05/28/1997 | CN1150754A Human osteoclast-derived cathepsin |
| 05/28/1997 | CN1150649A Enzyme linked immunosorbent assay kit for Leym disease |
| 05/28/1997 | CA2163828A1 Process for screening factors on a paralysis model and process for preparing said model |